FAKTOR OPTIONSSCHEIN - QUEST DIAGNOSTICS | Market Closed - Deutsche Boerse AG 15:50:35 2024-05-22 EDT | ||
| 8.6 EUR | -20.74% |
|
| Current month | +1.65% | ||
| 1 month | +82.98% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
| Date | Price | Change |
|---|---|---|
| 24-05-22 | 8.6 | -20.74% |
| 24-05-21 | 10.85 | -8.52% |
| 24-05-20 | 11.86 | +2.86% |
| 24-05-17 | 11.53 | +14.50% |
| 24-05-16 | 10.07 | +21.33% |
Delayed Quote Deutsche Boerse AG
Last update May 22, 2024 at 03:50 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | 
BNP Paribas
|
| WKN | PC15QD |
| ISIN | DE000PC15QD7 |
| Date issued | 2023-11-07 |
| Strike | 143.3 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 50 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 78.35 € |
|---|---|
| Lowest since issue | 2.56 € |
| Spread | 0.43 € |
| Spread % | 4.63% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
141.9
USD
Average target price
146.8
USD
Spread / Average Target
+3.48%
- Stock Market
- Certificates
- Certificat
